Company facts
- Headquarters
- Boca Raton, Florida
- Most recent report
- 8-K, filed Sep 2, 2026
- Incorporated
- California
- Filings on record
- 349 filings
- On EDGAR
- CIK 1119643
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 94
News 8 of 60
- 8-K Current report on a material event Sep 2, 2026
- 8-K Current report on a material event Sep 3, 2025
- 8-K Leadership change Mar 22, 2024
- 8-K Current report on a material event Aug 4, 2022
- 8-K Current report on a material event Oct 9, 2018
- 8-K Other events Sep 28, 2018
- 8-K Leadership change Mar 7, 2018
- 8-K Current report on a material event Nov 3, 2017
Prospectuses and Registrations 4
Proxies 3
Ownership 8 of 75
- SCHEDULE 13D Large holder reported an active stake Sep 1, 2026
- 3 Insider reported their initial holding Sep 1, 2026
- 4 Insider reported a trade Sep 1, 2026
- 5 Insider reported deferred transactions Jan 14, 2022
- SC 13D/A Large holder reported an active stake, amended Jan 14, 2022
- SC 13D Large holder reported an active stake Jun 29, 2018
- 4 Insider reported a trade Jun 26, 2018
- SC 13D Large holder reported an active stake Jun 6, 2018
Other 8 of 113
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2026
- NT 10-Q Notice that a quarterly report will be late Nov 15, 2022
- NT 10-Q Notice that a quarterly report will be late Aug 15, 2022
- NT 10-Q Notice that a quarterly report will be late May 16, 2022
- NT 10-K Notice that an annual report will be late Apr 1, 2022
- DEF 14C Mar 24, 2022
- PRE 14C Jan 14, 2022
- NT 10-K Notice that an annual report will be late Apr 1, 2019
Everything here comes from Nutra Pharma Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.